Abstract
Introduction: There may be causes of mediastinal lymph node enlargement other than metastasis in cancer patients and anthracosis is one of them. Aim: The aim of this study was to evaluate if anthracotic lymph node detected by endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) is a sign of benign conditions and excludes metastasis. Methods: Patients who underwent EBUS-TBNA for lung cancer staging or diagnosing mediastinal lymph node metastasis of ETM were included. Patients with EBUS-TBNA cytology reported as anthracotic pigments and also benign, malignancy or granulomatous inflammation were excluded. After EBUS-TBNA patients were underwent mediastinoscopy or radiological follow-up.If mediastinoscopic pathology was reported other than anthracosis or radiological follow-up showed lymph node enlargement,EBUS-TBNA was accepted as false negative. Results: Thirty one lung cancer and 19 ETM patients were included. Mediastinoscopy was performed in 23 lung cancer and 8 ETM patients. Remaing 8 lung cancer and 11 ETM patients were radiological follow-up. In lung cancer group, metastasis was reported with mediastinoscopy in 6 patients and 2 radiological follow-up patients had progression of lymph node enlargement. In ETM group only in 1 patient progression of lymph node enlargement was reported during radiological follow-up.As a result, EBUS-TBNA was false negative in 8 of 31 (25.8%) lung cancer patients and 1 of 19 (5.2%) ETM patients. Conclusion: In lung cancer patients anthracotic pigmentation of lymph nodes doesn9t exclude lymph node metastasis and mediastinoscopy should be performed before surgery. In extrathoracic malignancy patients, anthracotic pigmentation excludes metastasis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have